RP 31 Purus non-migration adhesive
Comprehensive performance to lead the pharmaceuticals market
Whenever labels are applied to liquid-filled LDPE containers, there’s a risk of adhesive migration – and a need for a non-migration adhesive. Replacing our RP 31 C adhesive, the new RP 31 Purus satisfies this requirement and many others that today’s pharmaceutical industry considers essential:
- Excellent mandrel hold, adhesive properties identical to our RP 31 C adhesive which it supersedes: be assured that the new RP 31 Purus works in all the same small-diameter applications.
- Secure supply: long-term raw material component supply promise to secure the stability required in the pharmaceutical market.
- Environmentally friendly APEO-free (alkyl phenol ethoxylate) formulation, compliant with EU DIRECTIVE 2003/53/EC.
- Approved by FDA and ISEGA, also for blood bag labelling.
- Suitable for sterilization by e-beam- and gamma radiation as well as EtO.
- Upgraded support documentation for Pharmaceutical companies: A new migration study and validation support package that will be supplied directly and uniquely to pharmaceutical companies upon request, to help them proceed with their homologation process: technical information, details of the RP 31 Purus formulation and extraction profile, and advice on conducting a leachable stability test.
Available with pharmaceutically proven faces
RP 31 Purus is supplied with our full range of pharmaceutically proven face materials to cover a broad spectrum of end-uses.
For more information, please contact your nearest UPM Raflatac representative.